Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy. - Mahmoud LM; Mageed AAAA; Saadallah JM; Youssef MF; Rashed LA; Ammar HI (Naunyn-Schmiedeberg's archives of pharmacology, 2024)